May 2004
Volume 45, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2004
Characterization of PRL–1, a human cone photoreceptor protein tyrosine phosphatase.
Author Affiliations & Notes
  • L. Yu
    Ophthalmology,
    Duke University Medical Center, Durham, NC
  • U. Kelly
    Ophthalmology,
    Duke University Medical Center, Durham, NC
  • J.N. Ebright
    Ophthalmology,
    Duke University Medical Center, Durham, NC
  • G. Malek
    Ophthalmology,
    Duke University Medical Center, Durham, NC
  • B.S. McKay
    Ophthalmology, University of Arizona College of Medicine, Tucson, AZ
  • C. Bowes Rickman
    Ophthalmology & Cell Biology,
    Duke University Medical Center, Durham, NC
  • Footnotes
    Commercial Relationships  L. Yu, None; U. Kelly, None; J.N. Ebright, None; G. Malek, None; B.S. McKay, None; C. Bowes Rickman, None.
  • Footnotes
    Support  NEI R01 EY11286, NEI P30 EY05722 & RPB CDA (cbr)
Investigative Ophthalmology & Visual Science May 2004, Vol.45, 1280. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      L. Yu, U. Kelly, J.N. Ebright, G. Malek, B.S. McKay, C. Bowes Rickman; Characterization of PRL–1, a human cone photoreceptor protein tyrosine phosphatase. . Invest. Ophthalmol. Vis. Sci. 2004;45(13):1280.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose: PRL–1 (phosphatase of regenerative liver–1), originally identified as an immediate early gene in the regenerating liver, was detected in a search for fovea–associated genes. We are interested in determining the function of this small, isoprenylated protein tyrosine phosphatase in the human retina. To this end we have developed biotools (antibodies, recombinant proteins, and transfected cell lines) to localize PRL–l within the retina. Methods: PRL–1 mRNA expression was analyzed in 4 mm diameter punches of macula and mid peripheral human retina by quantitative RT–PCR. Recombinant wildtype and ‘substrate–trap’ mutant (C104S) PRL–1 proteins were expressed with and without green fluorescent protein tags and purified, and affinity–purified polyclonal antibodies were prepared. In vitro phosphatase activities of the recombinant PRL–1s were assayed using p–nitrophenyl phosphate (pNPP). Immunohistochemical localization was determined on cryosections of human, monkey and pig retina labeled with anti–PRL–1 or anti–red/green or blue opsin antibodies. Western blots of human macula or mid–peripheral retina and RPE tissue extracts partitioned into membrane and cytoplasm fractions were labeled with antibodies against PRL–1. Endogenous PRL–1 was isolated from human retinal lysates separated by FPLC over a Mono Q column, run on 2D–gels and identified by MALDI–TOF and ES–MS/MS. Results: PRL–1 mRNAs were 1.6–fold more abundant in the adult human macula compared to the peripheral retina. Anti–PRL–1 antibodies labeled the outer segments of red/green, but not blue, cone photoreceptors. The affinity–purified antibody, which reacted with recombinant PRL–1, detected a band of the predicted molecular weight (20 kD) in both the macula and peripheral sample, and was present in higher concentrations in the membrane fraction versus the cytoplasmic fraction. Assays of phosphatase activity demonstrated that the recombinant PRL–1 was active versus C104S mutant PRL–1,which was inactive. 2D plus ES–MS/MS analysis showed endogenous PRL–1 was 20 kD with a pI of 9. Conclusions:Our studies have demonstrated novel expression of PRL–1 in the neural retina where PRL–1 appears to be expressed in a subset of cones and is membrane–associated. Based on the cellular and subcellular localization of PRL–1 in the human retina, it may function in cone outer segment signal transduction, in a manner unrelated to its nuclear role in other tissues.

Keywords: photoreceptors • protein purification and characterization • signal transduction 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×